|Boris C. Pasche, M.D., Ph.D.|
Boris C. Pasche, M.D., Ph.D.
Boris C. Pasche, M.D., Ph.D., is a Professor of Medicine, Director of the Division of Hematology-Oncology and Deputy Director of the UAB Comprehensive Cancer Center. Dr. Pasche also holds the Martha Ann and David L. May Endowed Chair in Cancer Research.
A specialist in breast and colon cancer genetics, Dr. Pasche is internationally recognized for his basic science and clinical research. One of his most recent successes was a study that revealed one of the first genetic links between obesity and colon cancer as well as the discovery that decreased expression of the TGFBR1 gene is a major cause of colorectal cancer.
Dr. Pasche was recruited to UAB in 2008 from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, where he was an Associate Professor of Medicine and leader of the Cancer Genes and Molecular Targeting Program. He completed his education at the University of Lausanne in Switzerland and the Karolinska Institute in Stockholm, Sweden, where he received his M.D. and Ph.D. He completed postdoctoral training at Harvard University, followed by a residency at Cornell Medical Center and a fellowship in hematology-oncology at Memorial Sloan-Kettering Cancer Center.